214 related articles for article (PubMed ID: 25518990)
1. Novel metabotropic glutamate receptor 4 and glutamate receptor 8 therapeutics for the treatment of anxiety.
Raber J; Duvoisin RM
Expert Opin Investig Drugs; 2015 Apr; 24(4):519-28. PubMed ID: 25518990
[TBL] [Abstract][Full Text] [Related]
2. Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice.
Dobi A; Sartori SB; Busti D; Van der Putten H; Singewald N; Shigemoto R; Ferraguti F
Neuropharmacology; 2013 Mar; 66():274-89. PubMed ID: 22643400
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptors: their therapeutic potential in anxiety.
Spooren W; Lesage A; Lavreysen H; Gasparini F; Steckler T
Curr Top Behav Neurosci; 2010; 2():391-413. PubMed ID: 21309118
[TBL] [Abstract][Full Text] [Related]
4. Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7.
Jalan-Sakrikar N; Field JR; Klar R; Mattmann ME; Gregory KJ; Zamorano R; Engers DW; Bollinger SR; Weaver CD; Days EL; Lewis LM; Utley TJ; Hurtado M; Rigault D; Acher F; Walker AG; Melancon BJ; Wood MR; Lindsley CW; Conn PJ; Xiang Z; Hopkins CR; Niswender CM
ACS Chem Neurosci; 2014 Dec; 5(12):1221-37. PubMed ID: 25225882
[TBL] [Abstract][Full Text] [Related]
5. The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders?
Pitsikas N
Eur J Pharmacol; 2014 Jan; 723():181-4. PubMed ID: 24361306
[TBL] [Abstract][Full Text] [Related]
6. Related functions of mGlu4 and mGlu8.
Davis MJ; Duvoisin RM; Raber J
Pharmacol Biochem Behav; 2013 Oct; 111():11-6. PubMed ID: 23948069
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of group III metabotropic glutamate receptors.
Lavreysen H; Dautzenberg FM
Curr Med Chem; 2008; 15(7):671-84. PubMed ID: 18336281
[TBL] [Abstract][Full Text] [Related]
8. Roles of metabotropic glutamate receptor 8 in neuropsychiatric and neurological disorders.
Mao LM; Mathur N; Shah K; Wang JQ
Int Rev Neurobiol; 2023; 168():349-366. PubMed ID: 36868634
[TBL] [Abstract][Full Text] [Related]
9. mGlu5 receptor antagonists: a novel class of anxiolytics?
Spooren W; Gasparini F
Drug News Perspect; 2004 May; 17(4):251-7. PubMed ID: 15334174
[TBL] [Abstract][Full Text] [Related]
10. Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature.
Lindsley CW; Hopkins CR
Expert Opin Ther Pat; 2012 May; 22(5):461-81. PubMed ID: 22506633
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of mGlu(7) and mGlu(8) in amygdala-dependent behavior and physiology.
Fendt M; Imobersteg S; Peterlik D; Chaperon F; Mattes C; Wittmann C; Olpe HR; Mosbacher J; Vranesic I; van der Putten H; McAllister KH; Flor PJ; Gee CE
Neuropharmacology; 2013 Sep; 72():215-23. PubMed ID: 23664812
[TBL] [Abstract][Full Text] [Related]
12. Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse.
O'Connor RM; Thakker DR; Schmutz M; van der Putten H; Hoyer D; Flor PJ; Cryan JF
Neuropharmacology; 2013 Sep; 72():66-73. PubMed ID: 23603202
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.
Litim N; Morissette M; Di Paolo T
Neuropharmacology; 2017 Mar; 115():166-179. PubMed ID: 27055772
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders.
Gregory KJ; Noetzel MJ; Niswender CM
Prog Mol Biol Transl Sci; 2013; 115():61-121. PubMed ID: 23415092
[TBL] [Abstract][Full Text] [Related]
15. Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.
Dogra S; Conn PJ
Neuropharmacology; 2021 Sep; 196():108687. PubMed ID: 34175327
[TBL] [Abstract][Full Text] [Related]
16. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.
Schoepp DD
J Pharmacol Exp Ther; 2001 Oct; 299(1):12-20. PubMed ID: 11561058
[TBL] [Abstract][Full Text] [Related]
17. Functional Dissociation of Group III Metabotropic Glutamate Receptors Revealed by Direct Comparison between the Behavioral Profiles of Knockout Mouse Lines.
Goddyn H; Callaerts-Vegh Z; D'Hooge R
Int J Neuropsychopharmacol; 2015 May; 18(11):pyv053. PubMed ID: 25999589
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic glutamate receptor 7: at the interface of cognition and emotion.
O'Connor RM; Finger BC; Flor PJ; Cryan JF
Eur J Pharmacol; 2010 Aug; 639(1-3):123-31. PubMed ID: 20371242
[TBL] [Abstract][Full Text] [Related]
19. mGlu receptors and drug addiction.
Cleva RM; Olive MF
Wiley Interdiscip Rev Membr Transp Signal; 2012 May; 1(3):281-295. PubMed ID: 22662312
[TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.
Swanson CJ; Bures M; Johnson MP; Linden AM; Monn JA; Schoepp DD
Nat Rev Drug Discov; 2005 Feb; 4(2):131-44. PubMed ID: 15665858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
